Dec 29, 2014

Farmak brought Keywer, an anaesthetic and anti-inflammatory medicine, to the market

Farmak, a domestic leader of the pharmaceutical market, continues extending the portfolio of anti-inflammatory and anaesthetic products. Thus, a new product, Keywer, solution for injection 50 mg/ml 2 ml No 10 and tablets 25 mg No 10 is introduced to the market.

Keywer, solution for injection, is recommended for:

Symptomatic treatment of acute moderate and severe pain when oral administration is unreasonable, for instance, postoperative pain, renal colic and pain in the small of the back.

Keywer, tablets, is recommended for:

Symptomatic therapy of mild and moderate pain, for instance, musculoskeletal pain, dysmenorrhea, toothache.

Back to the News

Previous Next

More news

Farmak Transitions to Electronic Drug Dossiers (eCTD Fo...

As of August 18, 2025, Ukraine has introduced the mandatory submission of drug registration dossiers in the international eCTD (electronic Common Technical Document) format. In alignment with this regulatory shift, Farmak has fully transitioned to compiling and submitting its registration dossiers in eCTD format starting that same month. The eCTD is a global...

Sep 10, 2025

China, Sudan, Qatar, and Oman Joined Farmak’s Export Ma...

Farmak, the leader of the pharmaceutical market in Ukraine, has expanded its export geography: in the first half of 2025, China, Sudan, Qatar, and Oman joined the list of export destinations. Farmak exports a wide range of medicines, including anesthetics, contrast agents for MRI (magnetic resonance imaging), hormonal and cardiological drugs, ophthalmic and ...

Sep 02, 2025

Zhebrivski Family Charitable Foundation Ranked Among th...

The Zhebrivski Family Charitable Foundation has been included in the TOP 100+ Publicly Transparent Philanthropic Organizations of Ukraine based on the results of its activities in 2024. This ranking is compiled annually by the Association of Philanthropists of Ukraine on the basis of official financial reporting. In 2024, the Zhebrivski Family Charitable Fou...

Aug 28, 2025